0

plasma cell dyscrasia icd 9

The 2002 Report on the Findings of Rating The Utah/Missouri ICD-9-CM Adverse Event Codes potx

The 2002 Report on the Findings of Rating The Utah/Missouri ICD-9-CM Adverse Event Codes potx

Tổ chức sự kiện

... drug induced diagnoses ( 292 .11, 292 .12, 292 .2, 292 .81, 292 .83, 292 .84, 292 . 89, 292 .9) , neuroleptic malignant syndrome (333 .92 ), reaction to spinal/lumbarpuncture (3 49. 0), polyneuropathy due ... ErrorMedicalCareMedian1 091 4.00 1.00 5.00 3 .96 75 1.2 391 2 717 .074HarmMedian10 69 2.00 3.00 5.00 4.0702 . 697 94 160 .075PreventMedian10 69 3.00 2.00 5.00 3.4677 .57665 .91 1 .075Valid N 10 69 Medical Care ... was compiled.Sources for the Selected ICD- 9 Codes as Adverse Events1. Utah Department of Health. 2001. Adverse Events Related to Medical Care, Utah: 199 5 -99 .(Robert Rolfs’ list) (AHRQ Grantee).2....
  • 11
  • 534
  • 0
Chapter 106. Plasma Cell Disorders (Part 1) ppsx

Chapter 106. Plasma Cell Disorders (Part 1) ppsx

Sức khỏe giới tính

... (Part 1) Harrison's Internal Medicine > Chapter 106. Plasma Cell Disorders Plasma Cell Disorders: Introduction The plasma cell disorders are monoclonal neoplasms related to each other ... process is lost. The clinical manifestations of all the plasma cell disorders relate to the expansion of the neoplastic cells, to the secretion of cell products (immunoglobulin molecules or subunits, ... maturation to antibody-secreting plasma cells is stimulated by exposure to the antigen for which the surface immunoglobulin is specific; however, in the plasma cell disorders the control over...
  • 5
  • 264
  • 0
Chapter 106. Plasma Cell Disorders (Part 2) potx

Chapter 106. Plasma Cell Disorders (Part 2) potx

Sức khỏe giới tính

... petroleum products. The neoplastic event in myeloma may involve cells earlier in B cell differentiation than the plasma cell. Circulating B cells bearing surface immunoglobulin that share the clear ... containing the Golgi apparatus. Binucleate and multinucleate malignant plasma cells can be seen. Chapter 106. Plasma Cell Disorders (Part 2) Figure 106-1 Representative patterns ... product of a single cell produces a "church spire" sharp peak, usually in the γ globulin region (bottom panel). The nature of the M component is variable in plasma cell disorders....
  • 5
  • 275
  • 0
Chapter 106. Plasma Cell Disorders (Part 3) ppsx

Chapter 106. Plasma Cell Disorders (Part 3) ppsx

Sức khỏe giới tính

... of Multiple Myeloma Chapter 106. Plasma Cell Disorders (Part 3) Incidence and Prevalence About 19, 900 cases of myeloma were diagnosed in 2007, and 10, 790 people died from the disease in ... Figure 106-3 Pathogenesis of multiple myeloma. Multiple myeloma cells interact with bone marrow stromal cells and extracellular matrix proteins via adhesion molecules, triggering adhesion-mediated ... bone lesions, bone pain Tumor expansion, production of osteoclast activating factor by tumor cells, osteoblast inhibitory factors Renal failure Hypercalcemia, light chain deposition, amyloidosis,...
  • 5
  • 332
  • 0
Chapter 106. Plasma Cell Disorders (Part 4) ppt

Chapter 106. Plasma Cell Disorders (Part 4) ppt

Sức khỏe giới tính

... polysaccharide antigens such as those on bacterial cell walls. Most measures of T cell function in myeloma are normal, but a subset of CD4+ cells may be decreased. Granulocyte lysozyme is plain ... tumor cells, activation of osteoclasts that destroy bone, and suppression of osteoblasts that form new bone. The osteoclasts respond to osteoclast activating factors (OAF) made by the myeloma cells ... Chapter 106. Plasma Cell Disorders (Part 4) Bone pain is the most common symptom in myeloma, affecting nearly...
  • 5
  • 298
  • 0
Chapter 106. Plasma Cell Disorders (Part 5) pot

Chapter 106. Plasma Cell Disorders (Part 5) pot

Sức khỏe giới tính

... Symptomatic multiple myeloma M protein in serum and/or urine Bone marrow (clonal) plasma cellsb or plasmacytoma Myeloma-related organ or tissue impairment (end organ damage, including ... immunofixation Bone marrow clonal plasmacytosis ≥10% or plasmacytoma Myeloma-related organ or tissue impairment (end organ damage, including bone lesions)a Solitary plasmacytoma of bone No ... and/or urinec Single area of bone destruction due to clonal plasma cells Bone marrow not consistent with multiple myeloma plasmacytosis. Both tumors are highly responsive to local radiation...
  • 7
  • 317
  • 0
Tài liệu Báo cáo khoa học: A novel splice variant of occludin deleted in exon 9 and its role in cell apoptosis and invasion docx

Tài liệu Báo cáo khoa học: A novel splice variant of occludin deleted in exon 9 and its role in cell apoptosis and invasion docx

Báo cáo khoa học

... and Huh7 cells transfected with pCMV ⁄ HA-OccWTor pCMV ⁄ HA-OccDE9. Cont, pCMV ⁄ HA-transfectedcells; WT, OccWT-overexpressing cells; DE9, OccDE9-overexpressingcells.Exon 9 of occludin ... experiments. Cont, pCMV ⁄ HA-transfected cells; WT, OccWT-over-expressing cells; DE9, OccDE9-overexpressing cells; +, 2-APB-treated cells; *P < 0.05.Exon 9 of occludin in apoptosis and invasion ... Hep3Band Huh7 cells transfected with pCMV ⁄ HA, pCMV ⁄ HA-OccWTorpCMV ⁄ HA-OccDE9. Cont, pCMV ⁄ HA-transfected cells; WT, OccWT-overexpressing cells; DE9, OccDE9-overexpressing cells.J...
  • 12
  • 613
  • 0
Báo cáo khoa học: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-jB1 ppt

Báo cáo khoa học: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-jB1 ppt

Báo cáo khoa học

... apoptosis. Onco-gene 22, 896 1– 898 2.MiR -9 inhibits ovarian cancer cell growth L M. Guo et al.5546 FEBS Journal 276 (20 09) 5537–5546 ª 20 09 The Authors Journal compilation ª 20 09 FEBS[13], thyroid ... Guo et al. MiR -9 inhibits ovarian cancer cell growthFEBS Journal 276 (20 09) 5537–5546 ª 20 09 The Authors Journal compilation ª 20 09 FEBS 5543MicroRNA -9 inhibits ovarian cancer cell growth throughregulation ... 0.05).MiR -9 inhibits ovarian cancer cell growth L M. Guo et al.5538 FEBS Journal 276 (20 09) 5537–5546 ª 20 09 The Authors Journal compilation ª 20 09 FEBSNF-jB1 is a candidate target of miR -9 According...
  • 10
  • 413
  • 0
05 Welding processes 9 plasma

05 Welding processes 9 plasma

Cơ khí - Chế tạo máy

... Plasma Arc Welding1. Principle2. Operating Modes3. Limitations and Advantages4. Common Applications5. Consumables6. Equipment7. Joint Design8. Process Control 9. Quality Control ... temperature and high heat concentration allow for the keyhole effectiv. Higher Travel speeds Plasma Arc Welding1. PrincipleAn arc welding process that uses a constricted arc betweena non...
  • 4
  • 362
  • 0
Báo cáo sinh học:

Báo cáo sinh học: "Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-g in patients with chronic heart failure" potx

Hóa học - Dầu khí

... of Translational Medicine 2011, 9: 28http://www.translational-medicine.com/content /9/ 1/28Page 3 of 7RESEARCH Open AccessIncrease of plasma IL -9 and decrease of plasma IL-5,IL-7, and IFN-g in ... is theincrease of IL -9 and decrease of IL-5, IL-7, and IFN-g plasma levels, in both ICM and NIDCM CHF patientsvs controls and the inverse correlation of IL-5 and IL- 9 plasma levels with duration ... ± 7.0LVIDd mm 62 ± 8.83 69 ± 9. 53Medications %Β-Antagonists 86 92 ACE-inhibitors 58 75Loop diuretics 70 13Aldosterone antagonists 34 46Digitoxin 4 21*Nitrate 9 3* p < 0.05 vs ICM.Cappuzzello...
  • 7
  • 424
  • 0
báo cáo hóa học:

báo cáo hóa học:" Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-g in patients with chronic heart failure" pptx

Hóa học - Dầu khí

... (LVEF) while IL-5 plasma levelsinversely correlated with disea se duration, in NYHA III/IV ICM patients.This is the first time that both an increase of plasma IL -9, and a decrease of plasma IL-5, ... is theincrease of IL -9 and decrease of IL-5, IL-7, and IFN-g plasma levels, in both ICM and NIDCM CHF patientsvs controls and the inverse correlation of IL-5 and IL- 9 plasma levels with duration ... ± 7.0LVIDd mm 62 ± 8.83 69 ± 9. 53Medications %Β-Antagonists 86 92 ACE-inhibitors 58 75Loop diuretics 70 13Aldosterone antagonists 34 46Digitoxin 4 21*Nitrate 9 3* p < 0.05 vs ICM.Cappuzzello...
  • 7
  • 333
  • 0
Cell Metabolism Cell Homeostasis and Stress Response Part 9 doc

Cell Metabolism Cell Homeostasis and Stress Response Part 9 doc

Điện - Điện tử

... protein folding reaction. 199 9 Nat. Struct. Biol. 199 9; 6 :92 3 -92 6. Jacob M & Schmid FX. Protein folding as a diffusional process. Biochemistry 199 9; 38:13773-137 79. Jain NK & Roy I. ... cerevisiae. Biochem J. 199 9; 343Pt 3:621-626. Williams SP, Haggie PM & Brindle KM. 19F-NMR Measurements of the rotational mobility of proteins in vivo. Biophys J. 199 7; 72: 490 - 498 . Xie GC & ... Biochim Biophys Acta. 198 8; 95 2(1):83 -91 . Walsh JL, Keith TJ & Knull HR. Glycolytic enzyme interactions with tubulin and microtubules. Biochim. Biophys. Acta 198 9; 99 9(1):64-70. Welch MD,...
  • 15
  • 323
  • 0
LUYỆN ĐỌC TIẾNG ANH QUA CÁC TÁC PHẨM VĂN HỌC –The Black Tulip ALEXANDRE DUMAS CHAPTER 9 9. The Family Cell It was about midnight when poor Van pot

LUYỆN ĐỌC TIẾNG ANH QUA CÁC TÁC PHẨM VĂN HỌC –The Black Tulip ALEXANDRE DUMAS CHAPTER 9 9. The Family Cell It was about midnight when poor Van pot

Kỹ năng đọc tiếng Anh

... DUMAS CHAPTER 9 9. The Family Cell It was about midnight when poor Van Baerle was locked up in the prison of the Buytenhof. What Rosa foresaw had come to pass. On finding the cell of Cornelius ... the cell, violently slamming the door, and noisily drawing the bolts. Recovering his consciousness, Cornelius found himself alone, and recognised the room where he was, "the family cell, " ... who do not return." On the way which the despairing florist had to traverse to reach that cell he heard nothing but the barking of a dog, and saw nothing but the face of a young girl....
  • 8
  • 312
  • 0
Chapter 080. Cancer Cell Biology and Angiogenesis (Part 9) ppt

Chapter 080. Cancer Cell Biology and Angiogenesis (Part 9) ppt

Sức khỏe giới tính

... tumor cells. Novel drugs called proteasome inhibitors block the proteolysis of IκB, thereby preventing NFκB activation. For unexplained reasons, this is selectively toxic to tumor cells. Further ... activity in clinical studies against cutaneous T cell lymphoma (e.g., vorinostat) and some solid tumors. HDAC inhibitors may target cancer cells via a number of mechanisms including upregulation ... transcription in cancer cells will be at least partially reversed. Aberrant signal transduction pathways activate a number of transcription factors that promote tumor cell proliferation and...
  • 5
  • 358
  • 0

Xem thêm